• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.

PD153035 (Hydrochloride)

(CAS: 183322-45-4)

Suppliers of PD153035 (Hydrochloride)

Company Name Email Tel Country
BOC Sciences [email protected] 1-631-504-6093

Fax: 1-631-614-7828Purity: >98% Brand: BOC Sciences

Biochempartner Co., Ltd [email protected] 0086-13720134139; 0086-15971444841 China

Fax: Purity: 98% Brand: Biochempartner

CHEMSCENE, LLC [email protected] 732-484-9848 USA

Fax: 888-484-5008Purity: Brand:

Price and Availability: USD60/5mg () USD78/10mg ()

MedChemexpress Co., Ltd. [email protected] 609-228-6898 USA

Fax: 609-228-5909Purity: Brand:

Price and Availability: USD60/5mg () USD78/10mg ()
Quality Control & MSDS Files: MSDS

Selleck Chemicals LLC [email protected] +1-832-582-8158 USA

Fax: +1-832-582-8590Purity: >98% Brand:

Price and Availability: USD90/10mg (In stock) USD370/50mg (In stock) USD970/200mg (In stock)
Quality Control & MSDS Files: HNMR HPLC

Shanghai Haoyuan Chemexpress Co., Ltd. [email protected] +86 (21) 5187-0955 / +86 (21) 5895-5995 China

Fax: +86 (21) 5895-5996Purity: Brand:

Price and Availability: USD60/5mg () USD78/10mg ()

Target Molecule Corp. [email protected] (857) 239-0968 USA

Fax: 857-239-8801Purity: .98 Brand: TargetMol

Price and Availability: USD75/10mg () USD133/25mg () USD213/50mg ()

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:
Remarks:
 

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of PD153035 (Hydrochloride)

PD153035 Hcl (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src. IC50 value: 5.2/29 pM(Ki/IC50) [1] Target: EGFR in vitro: PD 153035 shows a potent and selective inhibitory effect on tyrosine phosphorylation induced with EGF with IC50 of 15 nM and 14 nM in Swiss 3T3 fibroblast and A-431 human epidermoid carcinoma cells, respectively [1].

Solubility of PD153035 (Hydrochloride)

Solubility Sources
DMSO <1.2mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL MedChemexpress Co., Ltd.
(25°C) * In vitro DMSO 0.5 mg/mL (1.26 mM); Water<1 mg/mL (<1 mM); Ethanol<1 mg/mL (<1 mM); In vivo 30% Propylene glycol, 5% Tween 80, 65% D5W30 mg/mL Selleck Chemicals LLC

Storage Condition of PD153035 (Hydrochloride)

Storage Condition Sources

MSDS Information

MSDS Sources
MedChemexpress Co., Ltd.

Quality Control and Spectral Data

QC Reports Sources
[HNMR] [HPLC] Selleck Chemicals LLC

Mechanism and Indications

Signaling Pathways JAK/STAT Signaling Protein Tyrosine Kinase/RTK
Target EGFR
Research Area Cancer
Indications

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase
PD153035 (Hydrochloride) - Not Found
PD153035 (Hydrochloride) - No Development Reported

Chemical Information

M.Wt Formula CAS No. Synonyms
396.67 C16H15BrClN3O2 183322-45-4 N-(3-bromophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride

Structure Information of PD153035 (Hydrochloride)

Smiles COC1=CC2=NC=NC(NC3=CC=CC(Br)=C3)=C2C=C1OC.[H]Cl
InChI InChI=1S/C16H14BrN3O2.ClH/c1-21-14-7-12-13(8-15(14)22-2)18-9-19-16(12)20-11-5-3-4-10(17)6-11;/h3-9H,1-2H3,(H,18,19,20);1H

Related Products

Other Form Products of PD153035 (Hydrochloride)

Name CAS Formula Suppliers
PD153035 153436-54-5 C16H14BrN3O2 8

Recommended Products in Same Target

Name CAS Formula Suppliers
Ginsenoside Rh2 78214-33-2 C36H62O8 7
Mutated EGFR-IN-1 1421372-66-8 C25H31N7O 7
AZD-9291 (mesylate) 1421373-66-1 C29H37N7O5S 6
Mutant EGFR inhibitor 1421373-62-7 C27H30ClN7O2 6
AZD-9291 1421373-65-0 C28H33N7O2 18
WHI-P180 (hydrochloride) 153437-55-9 C16H16ClN3O3 5
WHI-P180 211555-08-7 C16H15N3O3 7
Gefitinib (hydrochloride) 184475-55-6 C22H25Cl2FN4O3 7
Erlotinib (mesylate) 248594-19-6 C23H27N3O7S 5
BGB-102 807640-87-5 C22H25BrN4O2 5
Poziotinib 1092364-38-9 C23H21Cl2FN4O3 12
CO-1686 (hydrobromide) 1446700-26-0 C27H29BrF3N7O3 11
CO-1686 1374640-70-6 C27H28F3N7O3 12
CNX-2006 1375465-09-0 C26H27F4N7O2 10
PD168393 194423-15-9 C17H13BrN4O 13
AG 18 118409-57-7 C10H6N2O2 16
Afatinib (dimaleate) 850140-73-7 C32H33ClFN5O11 11
Chrysophanol 481-74-3 C15H10O4 19
AG-1478 153436-53-4 C16H14ClN3O2 12
Mubritinib 366017-09-6 C25H23F3N4O2 24

Recommended Products in the Same Indication

Name CAS Formula Suppliers

Chemical and Physical Properties

Appearance:Light yellow to yellow Solid Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:

Tags: buy PD153035 (Hydrochloride) | PD153035 (Hydrochloride) IC50 | PD153035 (Hydrochloride) price | PD153035 (Hydrochloride) cost | PD153035 (Hydrochloride) solubility | PD153035 (Hydrochloride) purchase | PD153035 (Hydrochloride) manufacturer | PD153035 (Hydrochloride) research buy | PD153035 (Hydrochloride) order | PD153035 (Hydrochloride) MSDS | PD153035 (Hydrochloride) chemical structure | PD153035 (Hydrochloride) Storage condition | PD153035 (Hydrochloride) molecular weight | PD153035 (Hydrochloride) mw | PD153035 (Hydrochloride) datasheet | PD153035 (Hydrochloride) supplier | PD153035 (Hydrochloride) cell line | PD153035 (Hydrochloride) NMR | PD153035 (Hydrochloride) MS | PD153035 (Hydrochloride) IR | PD153035 (Hydrochloride) solubility | PD153035 (Hydrochloride) Safe information | PD153035 (Hydrochloride) Qc and Spectral Information | PD153035 (Hydrochloride) Clinical Information | PD153035 (Hydrochloride) Clinical Trial | PD153035 (Hydrochloride) Route of Synthesis | PD153035 (Hydrochloride) storage condition | PD153035 (Hydrochloride) diseases and conditions | PD153035 (Hydrochloride) flash point | PD153035 (Hydrochloride) boiling point | PD153035 (Hydrochloride) melting point | PD153035 (Hydrochloride) storage condition | PD153035 (Hydrochloride) brand